Researchers have shown that ginsenoside Rb1, via the miR-134-mediated BDNF signaling pathway, regulates hippocampal synaptic plasticity to improve depression symptoms (Wang et al., 2022). This evidence concerns the gene BDNF and major depressive disorder.